US$ 26.59
glp 1 switzerland Obesity drug cuts opiate craving | Science Targeting GLP-1, GIP & GCG
Description
Injectable GLP-1 receptor agonists such as semaglutide, liraglutide and exenatide have transformed care, but the shift toward oral alternatives points to a wider opportunity: creating solid oral dosage forms that improve patient experience without compromising performance

Glucagon-like peptide-1: new regulator in lipid metabolism

People with diabetes have had a hard time getting ahold of their medications because of the shortages, with some rationing their drugs to cope with the lack of supply, NPR reported

The British biotech was nominated as one of 2025s Fierce 15 biotechnology companies in September, the only one in the ranks to have been founded in 2025